← All trials
NCT01357031
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2010
- Primary completion
- Dec 1, 2011
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 192
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Albert Einstein Israelite HospitalLead sponsor
- Albert Einstein Israelite HospitalOverall official - principal investigator
- Fundação de Amparo à Pesquisa do Estado de São PauloCollaborator
- Albert Einstein Israelite HospitalReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.